Annie D'Agostino, Author at NJEDA

From left: Tayrex Co-Owner Frank Tayar, EDA Chief Executive Officer Melissa Orsen, Tayrex Co-Owner Eric Tayar.

TRENTON (October 17, 2016) – Software and consulting firm Tayrex Corporation was founded by the Tayar brothers over a decade ago to help businesses streamline operations. Headquartered in Lindenwold, with operations in Israel, the company creates custom applications for companies of various industries to improve areas such as warehouse fulfillment, dispatch systems, and customer relationship management.

In August, Tayrex Corporation closed on an $85,000 loan through the New Jersey Economic Development Authority’s (EDA) Small Business Fund to help the company launch a new product – Medulla Pro. The software will help field service engineers and technicians address a range of concerns, including pressure to bolster service-related revenue, combat real-time communication issues, and improve scheduling, routing and dispatch.

EDA Chief Executive Officer Melissa Orsen visited the company today as part of the EDA’s ongoing efforts to facilitate awareness of the programs it offers to support small and mid-sized businesses and not-for-profits.

“Family-owned small businesses like Tayrex represent the backbone of New Jersey’s economy,” Orsen said. “In this case, Tayrex’s mission is to improve the operations of other businesses, so the impact of their success is two-fold.”

The EDA’s activities to promote its programs in support of small businesses are based on the theme “EDA Was Here.” The campaign and new social media presence highlight how organizations like Tayrex have used the EDA’s financing programs to overcome challenges, meet their needs and grow. In 2015, the EDA closed on over $440 million in traditional financing assistance, including bonds for manufacturers and not-for-profit organizations. The Small Business Fund, under which Tayrex benefited, offers creditworthy small, minority-owned or women-owned businesses assistance of up to $500,000 and features an expedited approval process and fixed interest rates.

“As a family-owned software and consulting firm, we work closely with our clients to understand their vision so that we can provide the tools they need to work smarter, better and more effectively,” Tayrex Corporation Co-Founder Eric S. Tayar said. “The funding from this loan will help us achieve our goal of personalized service for each of our customers.”

To learn about EDA resources for small businesses and not-for-profits, visit

https://www.njeda.gov/small_midsize_business and follow @NJEDAWasHere on Twitter and LinkedIn.

The EDA is part of the state’s results-driven Partnership for Action. Created by Governor Christie and led by Lt. Governor Guadagno, the Partnership is the hub for all economic development activity in New Jersey and is comprised of four interconnected and highly focused organizational elements: Choose New Jersey, the Business Action Center, the Office of the Secretary of Higher Education and the EDA.

To learn more about opportunities for business growth throughout New Jersey, visit the state’s business portal at www.NewJerseyBusiness.gov or call the Business Action Center at (866) 534-7789.

###

TRENTON (October 14, 2016) – Continuing its efforts to bolster innovation in the Garden State, the New Jersey Economic Development Authority (EDA) today approved its 14^th venture fund investment. Action taken today will result in a limited partnership investment of up to $7.5 million in Tech Council Ventures II, which aims to invest in early-stage companies spanning key industries that are currently experiencing rapid growth.

“Since the days of Thomas Edison, New Jersey has always been a leader in innovation,” EDA Chief Executive Officer Melissa Orsen said. “Through investments in venture funds such as Tech Council Ventures II, the State routinely provides early-stage companies with much-needed capital that they can use to bring products to market or expand existing product lines. These investments have the dual benefit of keeping New Jersey at the forefront of innovation and creating jobs within the Garden State.”

Among its myriad of resources for the technology sector, the EDA helps increase available capital for emerging technology companies by investing as a limited partner in venture capital firms that invest in New Jersey-based enterprises. Investments made by the EDA are expected to earn a reasonable market rate return, which is measured in financial terms and by job growth. Gains resulting from these investments are utilized to offer new funding opportunities to support New Jersey businesses. Prior to today’s action, the EDA had approved investments in 13 venture capital funds totaling more than $42 million; these funds have leveraged the EDA’s investment in New Jersey technology businesses with private capital, by more than 62 times. The attraction of private investors into these companies demonstrates the credibility of the technology ecosystem in New Jersey and the attractiveness of investment opportunities in the state.

Tech Council Ventures II is the second fund formed in sponsorship and strategic partnership with the New Jersey Technology Council (NJTC). Tech Council Ventures II will seek to invest in 20 to 25 early-stage companies with an average initial investment of $500,000 to $2 million in fast-growing sectors, such as healthcare information technology, life sciences, education technology, financial technology, media technology and energy.

The EDA supported the predecessor vehicle formed in 2000, NJTC Fund I, with a $7.15 million limited partnership investment. The EDA’s investment to the $70 million fund resulted in a public/private leverage multiplier of 51.76 times the total $370 million of third party partner capital into New Jersey-based businesses. The 24 New Jersey companies that benefited have generated an estimated 1,983 jobs in the State. Achieve 3000, located in Lakewood, Fairfield-based Archive Systems, Cytosorbents in Monmouth Junction, and Power Survey, of Kearny, are among the two-dozen New Jersey businesses that leveraged funding from NJTC Fund I to thrive in the Garden State.

"As the leading association supporting and advocating for the technology community in New Jersey, we see Tech Council Ventures as a critical component of the resources we offer to nurture early-stage technology startups,” said James Barrood, President and CEO of the NJ Technology Council. “We appreciate the strong support of the EDA and believe this fund will make a big difference to the state's ecosystem.”

To stimulate growth of New Jersey’s innovation economy and drive commercialization of pioneering technology within the state, the EDA offers a continuum of assistance specifically designed to help technology and biotechnology companies at every stage of growth. From networking and mentoring to financial assistance such as loans and tax credits, hundreds of entrepreneurs, emerging businesses and established companies benefit from EDA support each year. Examples of this support include the New Jersey Angel Investor Tax Credit Program, the State’s Technology Business Tax Certificate Transfer (NOL) Program and resources available through the EDA’s Commercialization Center for Innovative Technologies.

To learn about resources available to support the technology industry, visit https://www.njeda.gov/tls and follow @NJEDATech on Twitter and LinkedIn.

The EDA is part of the State’s results-driven Partnership for Action. Created by Governor Christie and led by Lt. Governor Guadagno, the Partnership is the hub for all economic development activity in New Jersey and is comprised of four interconnected and highly focused organizational elements: Choose New Jersey, the Business Action Center, the Office of the Secretary of Higher Education and the EDA.

EDA Board meetings are typically held at 10 a.m. on the second Tuesday of each month at 36 West State Street in Trenton. The Board meeting schedule, as well as Board agendas and minutes, are available at www.njeda.gov. All Board actions will take effect at the expiration of the statutory period for the Governor’s review and consideration of the meeting minutes.

###

Michael J. Fox Foundation for Parkinson’s Research Chief Executive Officer Dr. Todd Sherer among headliners at the EDA's "Foundations are the New VCs Funding Panel" on Oct. 18.

North Brunswick, N.J. (October 13, 2016) – The Michael J. Fox Foundation for Parkinson’s Research (MJFF) Chief Executive Officer Dr. Todd Sherer and Andrea Yonah of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation will headline a funding panel discussion at the New Jersey Economic Development Authority’s (EDA) Commercialization Center for Innovative Technologies (CCIT) on Oct. 18. The event is being held in partnership with BioNJ.

Entitled “Foundations are the New VCs,” the free event will encourage New Jersey biotechnology companies to explore alternative research and development (R&D) funding sources from foundations like MJFF and BIRD. It will also address questions such as:

How will the next generation of drugs, diagnostics and devices be funded?
What new funding models might change the paradigm?
Is there an alternative way to fund early and emerging commercial biomedical research?

Dr. Sherer directs MJFF’s research strategy and is responsible for the Foundation’s overall scientific and fundraising direction to speed development of treatment and a cure for Parkinson’s disease. In 2015 alone, MJFF funded $87.8 million in research programs.

The BIRD Foundation works to encourage and facilitate cooperation between U.S. and Israeli companies in a wide range of technology sectors and offers funding to selected projects. Yonah noted that a pair of companies, one from the U.S. and one from Israel, can apply jointly for funding of up to 50 percent (maximum of $1 million) of the combined project budget. Since January 1, 2015, the BIRD Foundation has approved $23 million in funding for 28 projects, 11 of them in the life sciences sector.

Dr. Lisa Hague, Associate Manager of Technical Support at GENEWIZ, will also participate in the panel and will focus on how GENEWIZ benefited from the BIRD Foundation’s support. GENEWIZ is a CCIT graduate.
Biotechnology companies interested in attending can register online at https://www.njeda.gov/Press-Room/Events/CCIT-Foundations-are-the-New-VCs.

The event, which will be held from 3:00 p.m. to 5:00 p.m., is part of the EDA’s ongoing efforts to provide exposure to funding opportunities for New Jersey’s technology community.

“We often hear from the technology community how critical funding is to continuing development,” EDA CEO Melissa Orsen said. “That’s why the EDA frequently hosts opportunities, like the event on Oct. 18 and our New Jersey Founders and Funders event later this month, through which entrepreneurs can connect with those who can guide them to much needed capital.”

The event will also give biotechnology companies the chance to visit CCIT, a 46,000-square-foot incubator that is home to nearly two dozen businesses. With 27 wet labs and access to offices, conference rooms, a supportive staff and a variety of additional resources, CCIT is ideal for emerging companies looking to grow in the Garden State. CCIT is located within the Technology Centre of New Jersey, a 75-acre research park that houses such companies as Chromocell and Orthobond (both of which are CCIT graduates), Allergan, and Merial. Companies interested in touring CCIT should visit www.njeda.gov/CCIT or contact Lenzie Harcum at lharcum@njeda.com.

For more information about resources available to support New Jersey’s technology industry, visit https://www.njeda.gov/tls and follow @NJEDATech on Twitter and LinkedIn.

###

EDA President and Chief Operating Officer Tim Lizura and Hudson County Enterprises President Joseph Brown observe HCE employees at work

TRENTON (October 12, 2016) – With the goal of creating new jobs for residents, Jersey City-based Hudson Community Enterprises, Inc. (HCE) offers a range of education, training, and employment opportunities to youths and adults with disabilities and other barriers to employment. The 501(c)(3) not-for-profit corporation has business operations throughout New Jersey, and offers services such as vocational evaluation, work adjustment training, job placement, and individual and group counseling.

Since it opened its doors in 1957, HCE has placed thousands of residents into employment. Through its vocational rehabilitation programs, HCE currently employs more than 700 individuals, 80 percent of whom have disabilities.

The New Jersey Economic Development Authority (EDA) has supported HCE with tax-exempt bonds dating back to 1998, when the company used bond financing to expand its footprint in the Garden State. More recently, in 2012 and 2015, the organization again utilized this type of bond financing to support its needs.

“For nearly 60 years, our mission has been to create employment opportunities for community residents,” HCE President Joseph Brown said. “With EDA support, we were able to continue our efforts by refinancing conventional debt and acquiring machinery and equipment.”

To showcase HCE’s growth and to highlight financing opportunities available to small businesses throughout the Garden State, EDA President and Chief Operating Officer Tim Lizura today visited the company.

“A key objective of the EDA is to create new employment opportunities for residents throughout our state,” Lizura said. “Hearing the stories of those positively impacted through these vocational programs underscores the importance of supporting organizations such as HCE.”

The visit continues the EDA’s enhanced efforts to facilitate awareness of the programs it offers to support small and mid-sized businesses and not-for-profits, including a print and digital marketing campaign and social media channels. Centered on the theme “EDA Was Here,” the campaign and new social media presence highlight how organizations like HCE have used the EDA’s financing programs to overcome challenges, meet their needs and grow. In 2015, the EDA closed on over $443.5 million in traditional financing, including bonds to manufacturers and not-for-profit organizations, leveraging an estimated $669 million in total public/private investment.

To learn about EDA resources for small businesses and not-for-profits, visit https://www.njeda.gov/small_midsize_business and follow @NJEDAWasHere on Twitter and LinkedIn.

The EDA is part of the state’s results-driven Partnership for Action. Created by Governor Christie and led by Lt. Governor Guadagno, the Partnership is the hub for all economic development activity in New Jersey and is comprised of four interconnected and highly focused organizational elements: Choose New Jersey, the Business Action Center, the Office of the Secretary of Higher Education and the EDA.

To learn more about opportunities for business growth throughout New Jersey, visit the state’s business portal at www.NewJerseyBusiness.gov or call the Business Action Center at (866) 534-7789.

The New Jersey Economic Development Authority's next public Board Meeting will be held on Friday, October 14, 2016 at 10 a.m. at the EDA offices at 36 West State Street, Trenton. A copy of the proposed agenda can be found prior to the meeting at www.njeda.gov/Board. Following the Board Meeting, minutes and the full agenda will also be available at www.njeda.gov/Board.

The NOL Program has helped Agile Therapeutics secure funding to support operations during its IPO process. Al Altomari, President and Chief Executive Officer of Agile Therapeutics, is pictured above.

TRENTON (October 3, 2016) – Continuing its commitment to bolster the Garden State’s robust technology ecosystem, the New Jersey Economic Development Authority (EDA) announced today that 40 New Jersey technology and biotechnology companies have been approved to share over $35 million in Fiscal Year 2017 through the State’s Technology Business Tax Certificate Transfer (NOL) Program.

Administered by the EDA and the New Jersey Department of Treasury's Division of Taxation, this competitive program enables eligible technology and biotechnology companies to sell New Jersey tax losses and/or research and development tax credits to raise non-dilutive cash to finance their growth and operations.

“Entrepreneurs have long touted the NOL Program as critical to the continued growth of their companies,” EDA Chief Executive Officer Melissa Orsen said. “We routinely hear from the industry about the positive effects the program has on providing them with working capital they need to hire new employees or to further their development.”

Agile Therapeutics, a specialty pharmaceutical company in Princeton that focuses on the development of innovative women’s healthcare products, has repeatedly benefited from the NOL Program. The funding has helped Agile Therapeutics support operations during its IPO process.

“This program has been an important part of our overall funding strategy and we are very appreciative to have been a recipient of this valuable source of non-dilutive financing,” said Al Altomari, President and Chief Executive Officer of Agile. “Proceeds from the program have supported the advancement of our Phase 3 clinical study for our novel once-weekly low dose combined hormonal contraceptive patch that we expect to complete by the end of this year. Programs like this help make it possible for scientific advancements to take place here in the Garden State and we appreciate the strong support that New Jersey provides to our industry.”

Since the program was established in 1999, more than 500 unique businesses have been approved for awards totaling over $905 million. Sixteen companies are participating in the NOL program for the first time this year. Twenty-one companies have previously participated in other programs and initiatives offered by the State, such as the Angel Investor Tax Credit Program, the EDA’s semi-annual New Jersey Founders and Funders event, and additional resources available through the EDA’s Commercialization Center for Innovative Technologies (CCIT) in North Brunswick.

The following companies are among the 40 approved. A complete list of NOL award recipients can be found following this article and at https://www.njeda.gov/press-room.

ContraVir Pharmaceuticals is new to the NOL Program this year. Located in Edison, the biotechnology company is developing a cure for Hepatitis B through a combination of anti-viral compounds. The company’s pipeline also includes FV-100, which demonstrated the potential to reduce the prevalence of shingles-related pain in a Phase 2 clinical study and is currently in Phase 3 development.

“ContraVir is very excited to participate in this valuable program,” said James Sapirstein, CEO of ContraVir. “The funds will be used to move our clinical programs forward as well as increase our employee footprint in New Jersey. I relocated our company from out of state in order to take part in the NOL Program. We believe it will help to sustain the growth of our company and advance the development of our antiviral therapies.”

Hurel Corporation is another first-time participant. The company provides high-functioning, long-enduring in vitro liver models and microfluidic assay (testing) platforms that improve the predictive reliability of pre-clinical drug development and help reduce costly late-stage attrition in drug-makers' pipelines. After graduating from CCIT earlier this year, Hurel moved into its own dedicated laboratory space within the Technology Center of New Jersey’s campus in North Brunswick.

“Funding from the NOL will enable us expand our sales and marketing reach, and to continue to develop our prototype microfludic assay platform, trade-named HurelFlow™,” Hurel Chairman and CEO Robert Freedman said.

Vitals provides employers and health plans with cost and quality transparency tools that help consumers shop for health care. Based in Lyndhurst, the company also operates Vitals.com, a website that helps over 11 million consumers each month search for the best quality doctors in their areas.

“It’s a fantastic program and we’ve been active participants in it for a number of years now,” Vitals Chief Financial Officer Bryan Perler said of the NOL Program. “Our ability to sell net operating losses for cash enhances the company’s ability to invest even further in our technology and innovation for the future.”

Watchful Software is a four-year-old technology company headquartered in Marlton and producing data-centric security solutions that help banks and other financial institutions keep customers’ personal data safe from online hackers.

“Watchful Software is participating in the NOL program for the second year as we establish our business,” company CEO Tom Frommack said. “This ‘pay it forward’ approach has allowed us to accelerate our growth globally and has helped us manage our cash flow enabling us as entrepreneurs to compete and expand. We believe programs of this type help emerging companies expand and represent an enlightened approach to fostering business development in key growth sectors.”

To learn about these resources, visit https://www.njeda.gov/tls and follow @NJEDATech on Twitter and LinkedIn.

Company Municipality County

Acuitive Technologies, Inc.	Allendale	Bergen
Advaxis, Inc.	Princeton	Mercer
Agile Therapeutics Inc.	Princeton	Mercer
Angel Medical, Inc.	Shrewsbury	Monmouth
Applied Water Management, Inc.	Hillsborough	Somerset
Avlino Inc.	Holmdel	Monmouth
Bellerophon Therapeutics, Inc.	Warren	Somerset
BrilliantLight Power, Inc.	Cranbury	Middlesex
Cancer Genetics, Inc.	Rutherford	Bergen
CircleBlack, Inc.	Princeton	Mercer
Connotate, Inc.	New Brunswick	Middlesex
ContraVir Pharmaceuticals, Inc.	Edison	Middlesex
CytoSorbents Medical	Monmouth Junction	Middlesex
Edge Therapeutics, Inc.	Berkeley Heights	Union
Elite Laboratories, Inc.	Northvale	Bergen
Enteris BioPharma, Inc.	Boonton	Morris
EOS Energy Storage	Edison	Middlesex
Flowonix Medical Inc.	Mt. Olive	Morris
Fusar Technologies, Inc	Jersey City	Hudson
Hemispherx BioPharma	New Brunswick	Middlesex
Hurel Corporation	North Brunswick	Middlesex
Matinas BioPharma, Inc.	Bedminster	Somerset
MDx Medical Inc.	Lyndhurst	Bergen
Nanotech Industrial Solutions	Woodbridge	Middlesex
Ocean Power Technologies, Inc.	Pennington	Mercer
OncoBiologics Inc.	Cranbury	Middlesex
Rive Technology	South Brunswick	Middlesex
Roka BioScience, Inc.	Warren	Somerset
Scivantage, Incorporated	Jersey City	Hudson
Sight Logix, Inc.	Princeton	Mercer
Solidia Technologies	Piscataway	Somerset
Soligenix, Inc.	Princeton	Mercer
Svelte Medical Systems, Inc.	New Providence	Union
TAXIS Pharmaceuticals, Inc	Monmouth Junction	Middlesex
TelVue Corporation	Mt. Laurel	Burlington
Turnpoint Medical Devices	Basking Ridge	Somerset
United Silicon Carbide, Inc.	Monmouth Junction	Middlesex
Vitals	Lyndhurst	Bergen
Vydia, Inc.	Holmdel	Monmouth
Watchful Software, Inc.	Marlton	Burlington

A Special Meeting of the New Jersey Economic Development Authority has been scheduled for Friday September 30, 2016 at 11:00 a.m. in our offices at 36 West State Street, Trenton NJ. The Members will meet to discuss and act upon a request from Liberty Property Trust, Camden Waterfront Project, Closing Deadline Extension Request. The agenda can be found 48 hours prior at www.njeda.gov/Board.

Meet 1:1 with NIH and NSF SBIR/STTR representatives

TRENTON (September 28, 2016) – Early-stage technology and biotechnology companies seeking to learn about federal research and development (R&D) funding opportunities to advance innovative technologies to the commercialization stage are encouraged to attend a New Jersey Small Business Development Centers (NJSBDC) seminar on Friday, September 30. The program will be held at the New Jersey Economic Development Authority’s (EDA) Commercialization Center for Innovative Technologies (CCIT) in North Brunswick.

During the morning seminar, attendees will hear about Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs from representatives with the National Cancer Institute (NCI) and the National Institute of Allergy and Infectious Diseases (NIAiD), both of which fall within the National Institutes of Health, and the National Science Foundation (NSF). After lunch, participants will have the opportunity to meet one-on-one with representatives from each of the agencies.

Schedule speakers include:

Todd Haim, Ph.D., Program Director, NCI SBIR Development Center
Natalia Kruchinin, Ph.D., SBIR/STTR Program Coordinator, NIAID
Michael Minnicozzi, Ph.D., Program Officer, NIAID
Jesus Soriano, Ph.D., Program Director, NSF Smart Health and Biomedical Technologies
Randy Harmon, NJSBDC Technology Commercialization Consultant
Anthony Faugno, Certified Public Accountant, Partner, EisnerAmper
Vincent Smeraglia, Executive Director, Rutgers Office of Research Commercialization

CCIT Manager Lenzie Harcum noted that the NIH and NSF/SBIR are two of the eleven federal agencies obligated to expend approximately three percent of their annual extramural R&D budget to support entrepreneurs and small businesses undertaking research. This translates to approximately $2.5 billion in competitive grants available annually to fund small businesses through this program.

Companies wishing to meet 1-on-1 with program participants should email rgharmon@njsbdc.com and include a one-page overview of the technology, highlighting the specific objectives planned to accomplish with SBIR funding.

Visit www.njsbdc.com/sbir to view the agenda or to sign up.

For more information about resources available to support New Jersey’s technology industry, visit https://www.njeda.gov/tls and follow @NJEDATech on Twitter and LinkedIn.

###

CAD Signs Founder/CEO Alex Galeano speaks with EDA CEO Melissa Orsen

TRENTON (September 26, 2016) – When CAD Signs outgrew its leased facility in 2010, the New Jersey Economic Development Authority’s (EDAs) Small Business Fund helped the company acquire an expanded space in Hackensack. As a result, the commercial sign installation, maintenance and fabrication company has quadrupled its workforce and increased its customer base.

The EDA toured CAD Signs today to highlight the company’s growth and showcase the array of State resources available to help small businesses expand in New Jersey.

Established in 2005, CAD Signs offers a complete suite of assistance – from surveying and permit approvals to manufacturing and installation of signs – for companies of all sizes. The company also maintains signs following installation, including fixing lighting outages, LED retrofitting, and sign cleanup. While the company has a national reach, it has benefited from the abundance of corporations that call New Jersey home. In the Garden State, CAD Sign’s work can be seen at the GAF World Headquarters in Parsippany and Honeywell’s new campus in Morris Plains.

CAD Signs Founder and Chief Executive Officer Alex Galeano noted that his employee-oriented company routinely receives positive feedback from its clients.

“We service national sign companies, local developers, architects and marketing agencies that are looking for an experienced, established and reliable partner to execute their most important local and regional projects,” Galeano said. “The additional space and resources we have acquired with EDA’s support have helped us to grow our workforce and customer base and continue to provide the top-notch quality service our clients have come to expect.”

To accommodate its exceptional growth, CAD Signs purchased an additional facility adjacent to its current location in February of this year.

Through the EDA’s Small Business Fund, the company received a $696,000 PNC Bank loan backed by a 50 percent EDA guarantee. The Small Business Fund offers assistance to qualified businesses and not-for-profit organizations through direct loans, participations or guarantees, with a fixed interest rate and an expedited approval process. To be eligible, businesses must be in operation for at least one full year and not-for-profit corporations must be operating for at least three full years.

“Funding from the Small Business Fund helped CAD Signs not only expand its space, but also more than quadruple its workforce from eight to 40 over the last few years,” EDA CEO Melissa Orsen said. “We encourage all businesses to explore resources available through the State to help them grow.”

Today’s visit continues the EDA’s enhanced efforts to facilitate awareness of the programs it offers to support small and mid-sized businesses and not-for-profits, including a print and digital marketing campaign and social media channels. Centered on the theme “EDA Was Here,” the campaign and new social media presence highlight how organizations like CAD Signs have used the EDA’s financing programs to overcome challenges, meet their needs and grow. Through its small business lending programs, the EDA provided 55 companies with more than $32 million in assistance in 2015.

To learn about EDA resources for small businesses and not-for-profits, visit
https://www.njeda.gov/small_midsize_business and follow @NJEDAWasHere on Twitter and LinkedIn.

The EDA is part of the state’s results-driven Partnership for Action. Created by Governor Christie and led by Lt. Governor Guadagno, the Partnership is the hub for all economic development activity in New Jersey and is comprised of four interconnected and highly focused organizational elements: Choose New Jersey, the Business Action Center, the Office of the Secretary of Higher Education and the EDA.

To learn more about opportunities for business growth throughout New Jersey, visit the state’s business portal at www.NewJerseyBusiness.gov or call the Business Action Center at (866) 534-7789.

###